| 摘要 |
The invention relates to compounds of formula (I):wherein:A represents NR1C(Q)R2, C(Q)NR2R3 or NR1C(Q)NR2R3,B represents NR1C(Q)R2, C(Q)NR2R3, NR1C(Q)NR2R3, C(Q)OR1, NR1C(Q)OR2 or NR2R3,G1 and G3 represent an optionally substituted alkylene chain,Cy represents a ring structureandG2 represents a chainand medicinal products containing the same which are useful in treating or in preventing melatoninergic disorders. |
